Facultad de Medicina (FM)
Centro académico
Leiden University Medical Center
Leiden, HolandaPublikationen in Zusammenarbeit mit Forschern von Leiden University Medical Center (144)
2024
-
CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer
Molecular Therapy Nucleic Acids, Vol. 35, Núm. 2
-
Continuous innovation in precision radio-guided surgery
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 43, Núm. 1, pp. 39-54
-
Corrigendum to “European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO” [Eur J Surg Oncol 50 (1) (January 2024) 107292] (European Journal of Surgical Oncology (2024) 50(1), (S0748798323009307), (10.1016/j.ejso.2023.107292))
European Journal of Surgical Oncology
-
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO
European Journal of Surgical Oncology, Vol. 50, Núm. 1
-
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review
European Journal of Neurology, Vol. 31, Núm. 6
-
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 9, pp. 2706-2732
-
Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines
European Journal of Nuclear Medicine and Molecular Imaging
-
Non-Invasive Imaging Techniques for Diagnosis of Pelvic Deep Endometriosis and Endometriosis Classification Systems: An International Consensus Statement
Journal of Minimally Invasive Gynecology, Vol. 31, Núm. 7, pp. 557-573
-
Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S
European Journal of Neurology
-
Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines
Breast, Vol. 78
2023
-
Advanced MR Techniques for Preoperative Glioma Characterization: Part 1
Journal of Magnetic Resonance Imaging, Vol. 57, Núm. 6, pp. 1655-1675
-
Advanced MR Techniques for Preoperative Glioma Characterization: Part 2
Journal of Magnetic Resonance Imaging, Vol. 57, Núm. 6, pp. 1676-1695
-
Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort
Ultrasound in Obstetrics and Gynecology, Vol. 61, Núm. 2, pp. 231-242
-
COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses
Epidemiology and psychiatric sciences, Vol. 32, pp. e61
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy
European Journal of Cancer, Vol. 181, pp. 79-91
-
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Neuro-oncology, Vol. 25, Núm. 1, pp. 37-53
-
External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors into O-RADS Risk Groups
JAMA Oncology, Vol. 9, Núm. 2, pp. 225-233
-
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Molecular Therapy Nucleic Acids, Vol. 34
-
Role of LCN2 in a murine model of hindlimb ischemia and in peripheral artery disease patients, and its potential regulation by miR-138-5P
Atherosclerosis, Vol. 385